Page last updated: 2024-10-22

amifostine anhydrous and Osteoradionecrosis

amifostine anhydrous has been researched along with Osteoradionecrosis in 2 studies

Amifostine: A phosphorothioate proposed as a radiation-protective agent. It causes splenic vasodilation and may block autonomic ganglia.
amifostine : An organic thiophosphate that is the S-phospho derivative of 2-[(3-aminopropyl)amino]ethanethiol. A prodrug for the free thiol, WR-1065, which is used as a cytoprotectant in cancer chemotherapy and radiotherapy.

Osteoradionecrosis: Necrosis of bone following radiation injury.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Page, EE1
Deshpande, SS3
Nelson, NS2
Felice, PA2
Donneys, A2
Rodriguez, JJ1
Buchman, SR2
Gong, B1
Ahsan, S1
Tchanque-Fossuo, C1
Morris, MD1

Other Studies

2 other studies available for amifostine anhydrous and Osteoradionecrosis

ArticleYear
Prophylactic administration of Amifostine protects vessel thickness in the setting of irradiated bone.
    Journal of plastic, reconstructive & aesthetic surgery : JPRAS, 2015, Volume: 68, Issue:1

    Topics: Amifostine; Analysis of Variance; Animals; Dose Fractionation, Radiation; Dose-Response Relationship

2015
Raman spectroscopy delineates radiation-induced injury and partial rescue by amifostine in bone: a murine mandibular model.
    Journal of bone and mineral metabolism, 2015, Volume: 33, Issue:3

    Topics: Amifostine; Animals; Collagen; Male; Mandible; Osteoradionecrosis; Rats; Rats, Sprague-Dawley; Spect

2015